Vermamoeba vermiformis in hospital network: a benefit for Aeromonas hydrophila.


Journal

Parasitology research
ISSN: 1432-1955
Titre abrégé: Parasitol Res
Pays: Germany
ID NLM: 8703571

Informations de publication

Date de publication:
Nov 2019
Historique:
received: 25 07 2019
accepted: 04 09 2019
pubmed: 13 9 2019
medline: 26 12 2019
entrez: 13 9 2019
Statut: ppublish

Résumé

Aeromonas hydrophila, considered as an emerging pathogen, is increasingly involved in opportunistic human infections. This bacterium, mainly present in aquatic environments, can therefore develop relationships with the free-living amoeba Vermamoeba vermiformis in hospital water networks. We showed in this study that the joint presence of V. vermiformis and A. hydrophila led to an increased bacterial growth in the first 48 h of contact and moreover to the protection of the bacteria in adverse conditions even after 28 days. These results highlight the fact that strategies should be implemented to control the development of FLA in hospital water systems.

Identifiants

pubmed: 31511977
doi: 10.1007/s00436-019-06457-w
pii: 10.1007/s00436-019-06457-w
doi:

Substances chimiques

Water 059QF0KO0R

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3191-3194

Références

Front Microbiol. 2011 Apr 18;2:78
pubmed: 21747796
FEMS Microbiol Rev. 2019 Jul 1;43(4):415-434
pubmed: 31049565
Clin Microbiol Rev. 2004 Apr;17(2):413-33
pubmed: 15084508
Pathogens. 2015 Jun 09;4(2):373-86
pubmed: 26066311
Microb Ecol. 2018 Nov;76(4):991-1001
pubmed: 29737382
J Infect. 2011 Feb;62(2):109-18
pubmed: 21163298
Res Microbiol. 2014 Dec;165(10):847-51
pubmed: 25463386
Microb Pathog. 2019 May;130:81-94
pubmed: 30849490
Microb Pathog. 2015 Mar;80:14-20
pubmed: 25697664
Parasit Vectors. 2013 Jun 07;6:169
pubmed: 23742105

Auteurs

Vincent Delafont (V)

Laboratoire Ecologie et Biologie des Interactions, UMR CNRS 7267, Université de Poitiers, Poitiers, France. vincent.delafont@univ-poitiers.fr.

Estelle Perraud (E)

Laboratoire Ecologie et Biologie des Interactions, UMR CNRS 7267, Université de Poitiers, Poitiers, France.
Laboratoire de Parasitologie et Mycologie, CHU de Poitiers, Poitiers, France.

Kévin Brunet (K)

Laboratoire de Parasitologie et Mycologie, CHU de Poitiers, Poitiers, France.
Inserm U1070, Pôle Biologie Santé, 1 Rue Georges Bonnet, Poitiers, France.

Elodie Maisonneuve (E)

EA BIOS 4691, Université de Reims Champagne-Ardenne, 51097, Reims, France.

Sihem Kaaki (S)

Unité de pathologie ultrastructurale et expérimentale, Laboratoire d'anatomie et cytologie pathologiques, CHU la Milètrie, Poitiers, France.

Marie-Hélène Rodier (MH)

Laboratoire Ecologie et Biologie des Interactions, UMR CNRS 7267, Université de Poitiers, Poitiers, France.
Laboratoire de Parasitologie et Mycologie, CHU de Poitiers, Poitiers, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH